Originally published In Press as doi:10.1074/jbc.M208023200 on September 15, 2002
J. Biol. Chem., Vol. 277, Issue 47, 44801-44808, November 22, 2002
The Components of the Saccharomyces cerevisiae
Mannosyltransferase Complex M-Pol I Have Distinct Functions in Mannan
Synthesis*
Jürgen
Stolz
and
Sean
Munro§
From the MRC Laboratory of Molecular Biology, Hills Road, Cambridge
CB2 2QH, United Kingdom
Received for publication, August 6, 2002, and in revised form, September 12, 2002
 |
ABSTRACT |
The yeast Saccharomyces cerevisiae
processes N-linked glycans in the Golgi apparatus in two
different ways. Whereas most of the proteins of internal membranes
receive a simple core-type structure, a long branched polymer termed
mannan is attached to the glycans of many of the proteins destined for
the cell wall. The first step in mannan synthesis is the initiation and
extension of an
-1,6-linked polymannose backbone. This requires the
sequential action of two enzyme complexes, mannan polymerases (M-Pol) I
and II. M-Pol I contains the proteins Mnn9p and Van1p, although the stoichiometry and individual contributions to enzyme action are unclear. We report here that the two proteins are each present as a
single copy in the complex. Both proteins contain a DXD
motif found in the active site of many glycosyltransferases, and
mutations in this motif in Mnn9p or Van1p reveal that both proteins
contribute to mannose polymerization. However, the effects of these
mutations on both the in vivo and in vitro
activity are distinct, suggesting that the two proteins may have
different roles in the complex. Finally, we show that a simple
glycoprotein based on hen egg lysozyme can be used as a substrate for
modification by purified M-Pol I in vitro.
 |
INTRODUCTION |
N-linked glycans are attached to many of the secreted
and membrane proteins made by eukaryotic cells. The structures of
N-linked glycans vary greatly between species and between
individual proteins produced by a single species or cell type. This
diversity is generated by differential processing of an invariant
GlcNAc2Man9Glc3 structure that is
attached during insertion into the endoplasmic reticulum (ER).1 This is initially
trimmed by ER-localized glucosidases and mannosidases in a manner
that is not protein-specific but rather is linked to protein
folding (1). However, when the trimmed
GlcNAc2Man8-9 N-glycan arrives in
the Golgi it can be trimmed further by mannosidases and then modified
by many different glycosyltransferases to generate the observed
diversity of glycan structures (2, 3). Golgi glycosyltransferases vary
greatly between different species and cell types and can also show
substrate selectivity between the glycoprotein substrates expressed by
a given cell type. This results in the variation of glycosylation seen
between different species and also between the glycoproteins produced
by an individual cell.
The yeast Saccharomyces cerevisiae has proven useful for
identifying features of glycosyltransferase structure, function, and
targeting that are well conserved in higher eukaryotes. Yeast generate
just two main N-glycan structures, a small core-type structure found on many glycoproteins of internal compartments and a
large mannan structure found on proteins of the cell wall and the
periplasm (4, 5). The mannan structure contains ~100-300 mannoses
per N-glycan and constitutes 40% of the dry weight of the
yeast cell wall. Nonetheless mannan is not essential for viability (6,
7). Presumably because of their harsh natural environment yeast have
the ability to respond to cell wall damage or perturbation by
increasing the synthesis of cell wall components. Thus cells lacking
mannan are dependent for their viability on intact stress response
pathways, and have elevated levels of chitin and cell wall proteins
(8-12). This viability has facilitated the genetic analysis of the
steps of mannan synthesis, and combined with the altered chemical
sensitivities of glycosylation mutants (13-15), has allowed the
cloning of the relevant Golgi glycosyltransferases. The first step of
Golgi processing is the addition of a single
-1,6-linked mannose to
all N-glycans by the mannosyltransferase Och1p (16). The
next step is protein-specific (Fig. 1A). For proteins that
receive a core-type structure an as yet unidentified enzyme adds an
-1,2-linked mannose to the mannose added by Och1p, followed by
terminal
-1,3-linked mannoses from Mnn1p (17, 18). In contrast, on
mannoproteins an
-1,6-linked mannose is attached to the mannose
added by Och1p, and this is then extended to generate a long
-1,6-linked backbone which is then branched by the addition of
-1,2-linked and then
-1,3-linked mannoses (19, 20). The mannan
backbone is generated by two multiprotein complexes called mannan
polymerase (M-Pol) I and II (21-23).
At present it is not clear why some proteins receive mannan and others
do not. This issue is of relevance not only to the general biological
question of how glycan diversity is generated in the Golgi, but also to
the use of yeast as an expression system for the production of
recombinant glycoproteins. The M-Pol I complex is responsible for the
first committed step in the generation of mannan structure, and so
might be expected to play a role in substrate selection. Indeed, in
cells lacking the components of the complex, mannoproteins receive a
core-type structure (13, 24). The M-Pol I complex contains two related
proteins, Van1p and Mnn9p (22, 23). Both of these appear to be
canonical Golgi glycosyltransferases in that they are type II membrane
proteins with an N-terminal transmembrane domain (25-27). Moreover,
they both have a well conserved DXD motif that is also found
to be conserved in many families of nucleoside diphosphate sugar using glycosyltransferases (28-30). Structural studies on a number of enzymes have shown that these aspartate residues coordinate the Mn2+ ion that plays a central role in catalysis (31-34).
Moreover, the aspartates have been shown to necessary for the activity
of a wide range of glycosyltransferases (29, 35-38). In this paper we
determine the stoichiometry of Mnn9p and Van1p in M-Pol I, and use
mutations in their DXD motifs to investigate in
vivo and in vitro the contribution the two proteins
make to the activity of the complex.
 |
EXPERIMENTAL PROCEDURES |
Yeast Strains--
S. cerevisiae SEY6210
(MAT
ura3-52 leu2-3,112 his3-
200 trp1-
901 lys2-801
suc2
9) and SEY6211 (MATa ura3-52
leu2-3,112 his-3
200 trp1-
901 ade2-101 suc2
9) were used
as wild-type strains (39). Gene disruptions or C-terminal fusions to
Van1p or Mnn9p were generated by PCR-mediated homologous recombination
using the Schizosaccharomyces pombe his5+ gene
(40). Strains were checked by PCR or Western blotting. MNN1
was deleted using plasmid pDRMNN1, which contains 432 bp of the
MNN1 promoter and 542 bp of MNN1 terminator
sequences flanking the LEU2 gene in pUC19. Strain DT111
(MATa och1::LEU2 mns1 mnn1
ura3, Ref. 41) was a generous gift from Daniel Tessier (Biotechnology Research Institute, Montreal), and used for large scale
purification of lysozyme-G49N. The
och1
mnn1 strain was generated by sporulation of a cross of
XCY42-30D (MATura3 trp1 lys2 ade2-101
leu2-3,112
mnn1::LEU2, Ref. 25) with a
och1 strain (SEY6210
och1::HIS5Sp). The multiple
protease-deficient strain c13-ABYS 86 (MAT
pra1-1 prb1-1
prc1-1 cps1-3 ura3
5 leu2-3,112 his3; Ref. 42) was used for
expression of Och1p-ZZ.
Plasmid Constructs--
A cDNA encoding hen egg lysozyme was
mutagenized to change the codon for glycine 49 to asparagine
(QuickChange, Stratagene). The cDNA was cloned into yeast vectors
pVT100-U (43) for Western blot analysis, and pTG10241 (44) for
preparative purification of lysozyme-G49N. For co-expression of Mnn9p
and Van1p, VAN1-ZZ was cloned by gap repair from an
integrative transformant (23) and inserted into pRS424. The
MNN9 gene, isolated from a genomic clone as a
BstYI fragment containing 950 bp of promoter and 614 bp of
terminator sequences, was then ligated into the BamHI site of the resulting plasmid. AXD versions of MNN9
and VAN1-ZZ were generated by using the QuickChange kit
(Stratagene). Och1p was expressed in S. cerevisiae from
plasmid pVT100-U as a cytoplasmic protein, starting with the amino acid
sequence MLPTSS (where Leu (L) is amino acid 53 in the wild-type
protein) and a protein A tag at the C terminus (Och1p-ZZ).
To generate gene transplacements AXD versions of
VAN1 and MNN9 were generated by site-directed
mutagenesis. The mutagenic primers also encoded restriction sites to
allow for easy identification of mutants. The resulting
mnn9-AXD and van1-AXD forms were
inserted into YIplac211 (45), and the resulting plasmids linearized at restriction sites within the genes for integration at the wild-type locus. After selection for Ura+ transformants, the strains were grown
twice for 24 h in non-selective medium, and plated on
5-fluoroorotic acid to select for loss of the URA3 gene.
Mutants that had retained the AXD allele were identified by
restriction digestion of PCR amplification products.
Preparation of Yeast Total Membranes and
Immunoprecipitations--
Total membranes were isolated after breaking
yeast cells with glass beads in 25 mM Tris HCl, pH 7.5, 5 mM EDTA in the presence of protease inhibitors. After
removal of cell debris (3000 × g, 5 min), membranes
were pelleted (100,000 × g, 30 min), and 1 mg of
membrane protein was solubilized with 500 µl of 1% dodecylmaltoside in 10 mM triethanolamine, pH 7.5, 150 mM NaCl,
2 mM EDTA with protease inhibitors. After centrifugation
(100,000 × g, 30 min) the supernatant was incubated
with anti-HA monoclonal 12CA5 for 2 h at 4 °C, followed by
addition of 20 µl of protein A-Sepharose beads (Amersham Biosciences)
and incubation overnight. The beads were collected by filtration,
washed six times with 500 µl of the solubilization buffer now
containing 0.1% dodecylmaltoside and 1 mg/ml soybean trypsin
inhibitor, and bound proteins released with SDS sample buffer at
50 °C.
Preparation of Antisera against Mnn9p and Protein
Blotting--
A fragment of MNN9 encoding the C-terminal
part of the protein starting with amino acids
39LLGLNGQSISQH was ligated into the
His6-tagging expression vector pTrcHis A (Invitrogen) and
expressed in Escherichia coli BL21 (DE3) cells (Invitrogen)
as an insoluble protein. After purification on
nickel-nitrilotriaceticic acid-agarose (Qiagen) according to the
manufacturer's protocol, the protein was used for immunizations of
rabbits. The antiserum against hen egg lysozyme (Sigma) was a gift from
Mike Lewis, MRC-LMB. Antisera against lysozyme, Mnn9p and Van1p (23)
were affinity purified on antigen coupled to cyanogen bromide-activated
Sepharose (Amersham Biosciences). For protein blotting analysis of
secreted lysozyme-G49N, yeast strains transformed with the plasmid
pVT100-U-HELG49N were grown for 3 days. Protein from 1.8 ml of culture
supernatant was precipitated at 4 °C with 10% (w/v) of
trichloroacetic acid, washed twice with cold acetone, dried, and boiled
in SDS sample buffer for electrophoresis. A hybridoma supernatant
containing the anti-HA tag monoclonal antibody 12CA5 was used for
blotting at a 1:10 dilution. Peroxidase-conjugated anti-mouse or
anti-rabbit secondary antibodies were detected by chemiluminescence
(ECL, Amersham Biosciences).
In Vitro Assays of Mannosyltransferase
Activity--
Isolation of protein A-tagged M-Pol I complexes was
performed from 1 g (wet weight) of cells and followed published
procedures except the detergent used was 1% dodecylmaltoside for
solubilization and 0.1% dodecylmaltoside for washes (22, 23).
Mannosyltransferase assays contained 50 mM HEPES, pH 7.2, 10 mM MnCl2, 0.1% dodecylmaltoside, 10 mM
-1,6 D-mannobiose (Dextra Laboratories),
0.6 mM GDP-mannose, 62 nCi of
GDP-D-[U-14C]mannose (Amersham Biosciences).
Quantitation and fluorophore-assisted carbohydrate electrophoresis
(FACE) analysis of reaction products was done essentially as described
(23, 46). For mannosidase digestions
-1,6-mannosidase (New
England Biolabs) and
-1,2-mannosidase (Aspergillus
satoi, Glyko) were used in 50 mM ammonium acetate, pH
4.5.
Purification of Lysozyme-G49N Expressed in Yeast--
Strain
DT111, transformed with pTG10241-HELG49N, was grown in minimal medium
lacking uracil for 3 days. The medium was diluted 5-fold with 12.5 mM PIPES, pH 6.5, and 5 ml of settled SP Sepharose beads
(Amersham Biosciences) were added per liter of medium. After stirring
for at least 1 h at 4 °C, the beads were allowed to settle and
transferred to a column. After washing with 100 mM NaCl in 10 mM PIPES, pH 6.5, the protein was eluted with 500 mM NaCl in the same buffer, dialyzed against water,
concentrated by freeze-drying, dialyzed into PBS, and aliquoted for
storage at
20 °C.
Mannosyltransferase Reactions with Lysozyme-G49N as
Acceptor--
To generate a form of lysozyme suitable for modification
by M-Pol I, the protein purified from strain DT111 was first
mannosylated in vitro with Och1p. A soluble, protein
A-tagged form of Och1p expressed in yeast from the plasmid Och1p-ZZ
described above, was isolated with IgG-Sepharose from 0.1 g (wet
weight) of cells, and the beads were incubated with 8 µg of
lysozyme-G49N as acceptor protein in 60 µl of 50 mM
HEPES, pH 7.2, 0.5% Triton-X 100, 1 mM MnCl2,
0.6 mM unlabeled GDP-mannose for 7.5 h at 30 °C.
Reaction products were dialyzed against phosphate-buffered saline to
remove unused GDP-mannose and then incubated with M-Pol I complexes
immobilized on IgG-Sepharose beads. Reactions contained 50 mM HEPES, pH 7.2, 1 mM MnCl2, 125 nCi of GDP-D-[U-14C]mannose, 0.1%
dodecylmaltoside and 50 µl of beads containing M-Pol I complexes
prepared from 0.5 g (wet weight) of cells. Incubation was
performed for 7.5 h at 30 °C, followed by a brief
centrifugation to remove the beads. The supernatant was precipitated
with trichloroacetic acid, washed with acetone, and boiled in
SDS sample buffer for separation on a 15% gel. After Coomassie Blue
staining and drying, the gels were exposed to a PhosphorImager screen
(Typhoon, Molecular Dynamics).
 |
RESULTS |
Generation of an Antiserum against Mnn9p--
The Golgi-luminal
domain of Mnn9p was expressed in E. coli, and a polyclonal
antiserum was raised in rabbits against the recombinant protein. After
affinity purification the serum recognized a protein of 45 kDa in
protein blots of total extracts from wild-type cells (Fig.
1B), close to the predicted
molecular size of 45.8 kDa for Mnn9p, which has no sites for
N-linked glycosylation. This species is drastically
increased in abundance when the MNN9 is present on a
multicopy plasmid, is absent when MNN9 is deleted, and has reduced mobility when a triple HA epitope tag is inserted at the C
terminus of the MNN9 open reading frame. We conclude that
the serum specifically recognizes Mnn9p.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 1.
M-Pol I, M-Pol II, and their subunits.
A, a summary of the initial stages of glycoprotein
processing in the Golgi apparatus of S. cerevisiae. After
the action of Och1p, N-linked glycans can receive either a
mannan or a core-type structure. The -1,6-linked backbone of mannan
is synthesized by M-Pol I and M-Pol II, and then additional enzymes add
branches and phosphomannose (reviewed in Refs. 4 and 5). B,
protein blots of total protein extracts from 0.5 OD600
units of the indicated strains probed with the affinity-purified
anti-Mnn9p serum. C, protein blots of fractions obtained
during the precipitations from diploid strains that contain one allele
of either VAN1 or MNN9 tagged at the C terminus
with a triple HA tag (total lysate (total), supernatant
(s/n), and precipitate (HA-ip)). Total
membranes were solubilized and immunoprecipitated with the anti-HA
12CA5 monoclonal antibody and then probed with the indicated antisera.
In the case of MNN9, the lysate was depleted with 20 µl of
purified anti-Anp1p serum and protein A beads to remove M-Pol II prior
to the anti-HA immunoprecipitation. D, as in C,
except that the diploid strains contained single tagged alleles of
MNN9 or ANP1, and the lysates were not depleted
with anti-Anp1p.
|
|
M-Pol I Is a Heterodimer of Van1p and Mnn9p--
To investigate
the stoichiometry of Mnn9p and Van1p in M-Pol I, a diploid strain was
constructed in which one allele of the VAN1 gene was tagged
at the C terminus with a triple HA epitope tag. We have previously
found that when Van1p is tagged at the C terminus it retains its
activity and its association with Mnn9p (22, 23), and in the diploid
cells, the tagged and untagged proteins were present at comparable
levels when analyzed with a Van1p-specific serum (Fig. 1C).
The membranes from the tagged strain were solubilized with detergent,
and the lysate incubated with beads coated with the anti-HA monoclonal
antibody 12CA5. Fig. 1C shows that only Van1p-HA bound to
the beads, while the untagged Van1p remained in the supernatant. A
proportion of Mnn9p was also bound to the beads indicating that the
M-Pol I complexes remained intact during isolation. The free Mnn9p is
presumably associated with the untagged Van1p, and moreover Mnn9p,
unlike Van1p, is also present in the M-Pol II complex. Antisera against Anp1p, a component of M-Pol lI, showed that as expected this complex does not associate with Van1p-HA (Fig. 1C). The absence of
association between Van1p-HA and Van1p indicates that the M-Pol I
complex contains only a single copy of Van1p.
A similar strategy was used to analyze the stoichiometry of Mnn9p in
M-Pol I. Detergent lysates were prepared from a diploid strain in which
one copy of MNN9 was tagged with the triple HA epitope.
Since Mnn9p is present in both M-Pol I and M-Pol II, the latter complex
was initially depleted from the lysate using an anti-Anp1p serum. This
treatment removed all of the Anp1p (Fig. 1C) and more than
half of the Mnn9p from the lysate (data not shown). When the lysate was
then incubated with anti-HA monoclonal and protein A beads, all
remaining Mnn9p-HA was precipitated. In contrast, the untagged Mnn9p
remained in the supernatant. About half of the Van1p present after
removal of M-Pol II coprecipitated with Mnn9p-HA, indicating that the
M-Pol I complex had remained intact during the isolation procedure.
Taken together these results indicate that M-Pol I is a heterodimeric
complex consisting of one copy of Van1p and one copy of Mnn9p.
Interestingly, the situation with M-Pol II appears to be different. If
this complex was not removed with anti-Anp1p prior to precipitation of
Mnn9p-HA, then untagged Mnn9p is coisolated with Mnn9p-HA (Fig.
1D). A similar immunoprecipitation was performed on a
diploid strain carrying one tagged allele of ANP1. After precipitation with 12CA5 and protein A beads, untagged Anp1p
co-precipitated with Anp1p-HA, indicating that Anp1p is also present at
more than one copy in the M-Pol II complex (Fig. 1D).
Together, these results show that the overall architecture of M-Pol I
is simpler than the structure of M-Pol II, which involves five
subunits, at least two of which are present in multiple copies.
Inactivating Mutations in the Catalytic Domains Van1p and
Mnn9p--
The primary function of M-Pol I is to initiate and extend
the
-1,6-linked backbone of the mannan structure, and the complex has mannosyltransferase activity in vitro (22). This raises the question of what contribution the two proteins in the complex make
to the synthesis of the
-1,6-linked polymer. This cannot be
addressed by simply deleting the individual genes, as it has been found
that deletion of MNN9 results in greatly reduced levels of
both Van1p and Anp1p, presumably due to destabilization in the absence
of their normal binding partner (21, 22). We therefore made use of the
DXD motifs in Mnn9p and Van1p, which have been shown in
other glycosyltransferases to be present in the catalytic site and
essential for activity, but in those cases examined not required for
normal folding and assembly (28, 29). Thus mutant versions of
MNN9 and VAN1 were generated in which the
DXD motif was altered to AXD
(mnn9-AXD (D236A); and
van1-AXD (D361A)). The mutant alleles were used
to substitute the wild-type allele by gene transplacement (47), and
protein blotting indicated that the mutant proteins were present at
similar levels to those found in wild-type cells (data not shown).
Defects in mannan synthesis are known to result in a resistance to
vanadate (13), and Fig. 2A
shows that the mnn9-AXD and van1-AXD strains behave like the
mnn9 and
van1 deletion strains in that they
are capable of growing on 10 mM sodium vanadate. To
investigate whether the AXD mutations affect the ability of the proteins to associate, the wild-type and mutant forms of the two
genes were co-expressed from plasmids in all four possible combinations. In each case Van1p was tagged with protein A (Van1p-ZZ), and IgG-Sepharose was used to isolated the proteins from cell lysates.
Fig. 2B shows that Mnn9p coprecipitates with Van1p-ZZ on
IgG-Sepharose beads regardless of whether there is an AXD
mutation in MNN9 or VAN1 or both. Thus
mnn9-AXD and van1-AXD
alleles encode stable proteins that are capable of normal interactions
but appear to have defective activity.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 2.
Characterization of AXD
versions of Mnn9p and Van1p. A, strains that carry
disruptions or AXD alleles of MNN9 or
VAN1 were spotted on YPD plates containing 10 mM
sodium vanadate and incubated for 3 days at 30 °C. Strains
containing the HA-tagged versions of both genes were also analyzed.
B, anti-Mnn9p protein blots of IgG-Sepharose precipitations
from mnn9 strains expressing from 2-µ plasmids the
indicated combinations of untagged Mnn9p and protein-A tagged Van1p
(Van1p-ZZ). Total (t), unbound (ft), and bound
(b) fractions were analyzed. Due to the binding of rabbit
anti-Mnn9p to protein A, Van1p-ZZ is also detected on the blot. In each
case some Mnn9p does not bind to the IgG-Sepharose beads, presumably
because it is present in the M-Pol II complex.
|
|
Use of Hen Egg Lysozyme as an in Vivo Reporter of Protein
Glycosylation--
To analyze directly the effect of the
AXD mutations in MNN9 and VAN1 on
mannan synthesis we used as a reporter protein a glycosylated mutant of
hen egg lysozyme. The signal sequence of the avian protein is
functional in S. cerevisiae and the protein is secreted into the medium from which it can be readily purified by cation-exchange chromatography. When the protein is N-glycosylated on a
single sequon introduced by mutagenesis (G49N), it receives an
extensive mannan structure in the Golgi (48). This reporter has the
advantage that it is a small protein and so most of its mass is
contributed by the saccharide, increasing the ease of detecting changes
in glycan addition. Moreover the presence of only a single glycan means
that changes in the gel mobility should directly reflect changes in the
length of the glycan added. A similar glycosylated mutant of human
lysozyme has proven informative as a reporter of glycosylation in
mammalian cells (49, 50).
When expressed in yeast, wild-type lysozyme protein migrates as a 14 kDa protein, and, as previously reported, the G49N form has a greatly
reduced mobility, running as a smear of 150-200 kDa on an SDS gel
(Fig. 3A and Ref. 48). We did
not observe any reporter protein secreted with no N-linked
sugars or with only core structures attached, indicating that
modification and maturation are very efficient. Treatment with
endoglycosidase H (endo H) to release N-linked glycans,
restored the mobility of lysozyme-G49N to close to that of the
unmodified protein. More lysozyme is detected on the blot after
digestion, presumably because the highly glycosylated form of lysozyme
is only partially transferred from the gel during blotting.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 3.
Expression of a glycosylated form of hen egg
lysozyme in wild-type and glycosylation mutants of S. cerevisiae. A, protein blots of the media
from wild-type SEY6210 cells expressing wild-type or the G49N version
of lysozyme (HEL). Samples were digested with or without
endo H prior to gel electrophoresis, as indicated. The endo H product
of lysozyme-G49N consistently migrate slightly slower than the
wild-type lysozyme, presumably due to the
N-acetylglucosamine residue that remains after endo H
treatment. B, as in A, except that the
lysozyme-G49N expression plasmid was in the indicated glycosylation
mutants.
|
|
Having established that lysozyme-G49N behaved as expected in the
wild-type stain, we next examined how its mobility was affected by
deletion of particular Golgi glycosyltransferases. Fig. 3B shows that loss of the M-Pol II subunit Anp1p resulted in intermediate mobility while cell lacking Och1p and Mnn1p, and hence incapable of any
Golgi mannose addition to the ER-derived N-glycan structure, produced a rapidly migrating form (16 kDa). We next examined the effect
on glycosylation of the AXD mutations of Mnn9p and Van1p. mnn9-AXD and
mnn9 cells both
produce lysozyme-G49N with the same mobility, close to that of the
protein produced in
och1 cells, indicating a severe
defect in mannan synthesis. Combination of these mutations with a
deletion of MNN1 reduces the apparent molecular weight of
the lysozyme-G49N. Mnn1p is known to add 2-3
-1,3-linked mannoses
to the core-type structure (6, 18, 51), indicating that the loss of a
small number of mannoses leads to a detectable increase in gel
mobility. The van1-AXD mutation also results in severe defect in mannan synthesis, with the lysozyme-G49N having a
mobility similar to that seen in
van1 cells. However, the
lysozyme-G49N consistently migrated slightly slower than that produced
from
mnn9 or mnn9-AXD cells, both
in the absence of MNN1 (Fig. 3B) and in its
presence (data not shown). Taken together, these results indicate that
both Mnn9p and Van1p participate directly in the extension of the
mannan backbone by the M-Pol I complex. Moreover, it appears that when
Mnn9p is still active, more mannose can be attached than occurs when
only Van1p is active, indicating that the first step or steps in the
extension of the mannan backbone are mediated by Mnn9p rather than Van1p.
Mnn9p Acts as Both an
-1,2- and an
-1,6-Mannosyltransferase--
The M-Pol I complex has been
previously shown to have mannosyltransferase activity when assayed
in vitro (21-23). To correlate the effects of the
AXD mutations seen in vivo, with their effects on
the activity in vitro, M-Pol I was isolated from cells
expressing the 4 possible combinations of Van1p and Mnn9p as the
DXD or AXD versions. The various forms of the two
proteins were co-expressed from a plasmid in an
mnn9
mutant, and complexes isolated by use of a protein A tag fused to the C
terminus of the plasmid-borne Van1p (Van1p-ZZ). This strategy ensures
that the complexes immobilized on the IgG-Sepharose beads were entirely
encoded by the plasmid-borne copies of VAN1 and
MNN9.
The isolated complexes were assayed for ability to transfer
radioactivity from GDP-[14C]mannose to the acceptor
-1,6-mannobiose. Neutral reaction products were quantified by
scintillation counting or reacted with a fluorescent dye for analysis
by FACE (22, 46). The complexes containing an AXD mutation
in just one of the subunits still retained substantial mannosyltransferase activity in vitro, although more
remained after mutation of Mnn9p than of Van1p (55 versus
13%, Fig. 4A). If both were
mutated then no transferase activity was detected above background.
However, FACE analysis of the products of the two single mutant
complexes showed that the complex in which only Van1p is wild-type
produced a ladder of polymannose products of 3-7 mannose residues in
size. In contrast, the complex in which only Mnn9p is wild-type
produced only a mannose trimer, consistent with the lower incorporation
of radioactive mannose.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 4.
Mannosyltransferase activity of wild-type and
mutant versions of M-Pol I. A, mannosyltransferase activity
of M-Pol I complexes isolated from the indicated strains. The amount of
radioactivity transferred from GDP-[14C]mannose to the
acceptor -1,6-mannobiose was quantified by scintillation counting of
the neutral reaction products, and expressed as nmol of mannose
transferred per h per mg of starting membrane protein prior to
detergent solubilization. The experiment shown is representative of
three independent determinations, and the background signal produced by
a precipitation from a strain with no tagged protein was
indistinguishable from that seen with the
Mnn9pAXD-Van1pAXD complex (data not shown).
B, FACE gels of the reaction products from the indicated
complexes using the same donor and acceptor as in A. The
products were subject to digestion with the indicated mannosidases
prior to modification with the negative charged fluorophore
8-aminonaphthalene-1,3,6-trisulfonic acid and gel separation. The
resulting gels were exposed to a PhosphorImager screen for 10 days to
identify the radioactive products (upper panels) or
visualized by fluorescence with ultraviolet light (lower
panels). The glucose oligomer size ladder is visible in the latter
panels.
|
|
Previous analysis of the wild-type M-Pol I complex had shown that it
formed both
-1,6- and
-1,2-linkages (22, 23). Thus the products
of the two mutant complexes were digested with linkage-specific mannosidases. Fig. 4B shows that the complex with only Van1p
wild-type produced almost entirely
-1,6-bonds linkages. In contrast,
the trimers produced by the complex with only Mnn9p wild-type contained a mixture of
-1,6 and
-1,2 linkages. Quantification revealed that
more than 40% of the radioactivity appears in the form of monomeric
mannose after digestion with
-1,6-specific mannosidase. This is
consistent with previous analysis of the products of the wild-type
complex in which only mannose trimers were resistant to
-1,6-specific mannosidase (22). Taken together, these results show
that both proteins contribute
-1,6-transferase activity to the
complex, but that Mnn9p appears to also have the ability to attach
mannose via an
-1,2-linkage to at least a simple substrate, in this
case mannobiose.
In Vitro Mannosyltransferase Activity on a Glycoprotein
Substrate--
Many in vitro assays of glycosyltransferase
activity rely on small oligosaccharide substrates such as those used in
the assays above. However, the in vivo substrates of Golgi
glycosyltransferases are of course much larger glycoproteins. In the
case of M-Pol I these are proteins that contain ER-derived
GlcNAc2Man8-9 structures that have been then
modified in the Golgi by addition of an
-1,6-linked mannose by Och1p
(Fig. 1A). Therefore, we examined whether the glycosylated
variant of lysozyme could be used as a model glycoprotein substrate for
the in vitro reconstitution of outer chain initiation and
elongation by M-Pol I.
To obtain lysozyme-G49N with N-glycans in an ER form the
protein was expressed in a yeast strain DT111 that lacks
MNN1, OCH1, and MNS1, and has been
shown to produce glycoproteins with the form
GlcNAc2Man9 (41). The glycosylated lysozyme
produced by this strain was initially mannosylated by Och1p in
vitro. This could not be done in vivo as glycoproteins
produced in strains lacking M-Pol I, but containing Och1p, have an
additional
-1,2-linked mannose attached to the mannose added by
Och1p (13, 52). This linkage apparently precludes any further extension
of the mannan backbone and seemed likely to have same effect in
vitro. Thus we expressed Och1p as a fusion protein to protein A,
isolated it on IgG-Sepharose beads and used it to modify the
glycosylated lysozyme-G49N in vitro using GDP-mannose as a
donor (see "Experimental Procedures"). Control reactions using
radiolabeled GDP-mannose confirmed that the lysozyme-G49N was
mannosylated by Och1p in an MnCl2-dependant manner (data
not shown).
The Och1p-modified lysozyme-G49N was then used as an acceptor for
in vitro mannosyltransferase reactions with isolated M-Pol I
complexes immobilized on IgG-Sepharose. The donor was radiolabeled GDP-mannose, and the reaction products were separated on protein gels
and analyzed by Coomassie staining and autoradiography (Fig. 5). When M-Pol I containing
AXD mutation in either one or both of Mnn9p and Van1p was
used, the 16-kDa band corresponding to core-glycosylated lysozyme-G49N
received only trace labeling. This appears to be due in part to low
level contamination of Mnn1p and Och1p on the IgG-Sepharose beads (data
not shown). In contrast, the complex consisting of wild-type Van1p and
Mnn9p produced a striking incorporation of radioactivity into the
glycoprotein substrate. This leads to an increase in apparent molecular
size from 16 kDa to up to 40 kDa. This size is similar to that of the lysozyme-G49N produced by the
anp1 mutant in
vivo (Fig. 3A), suggesting that the complex has
considerable processivity in vitro. As expected this high
level of incorporation was not observed with complexes in which either
Mnn9p or Van1p contained the AXD mutation. However, because
of the trace labeling observed in all cases on the core-glycosylated
lysozyme-G49N it was not possible to determine whether the
Mnn9pAXD-Van1pDXD complex was still able to
attach an initiating mannose, as predicted from the in vivo results. Nonetheless, the reconstitution of outer chain mannosylation from the purified wild-type proteins suggests that all the proteins that are necessary to initiate the mannan outer chain are identified and that lysozyme-G49N can be directly recognized by the M-Pol I
complex.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 5.
In vitro mannosyltransferase
activity of M-Pol I with a glycoprotein substrate. Protein gel of
glycosylated lysozyme-G49N after treatment with
GDP-[14C]mannose and M-Pol I containing Mnn9p and Van1p
with either AXD mutations (A) or wild-type
(D) as indicated. The gel was stained with Coomassie Blue
and then dried and exposed to a PhosphorImager screen for 3 days. The
substrate lysozyme-G49N was expressed from the strain DT111 and
pretreated with cold GDP-mannose and Och1p-ZZ bound to IgG-Sepharose
beads. The protein was then used in the mannosyltransferase assays with
M-Pol I complexes bound to IgG-Sepharose via a protein A tag on Van1p.
Substantial labeling of lysozyme-G49N was only seen if both Mnn9p and
Van1p were wild-type, indicating that transfer of mannose to the
substrate was M-Pol I-dependent. A small amount of label
was apparently transferred even with both proteins being mutant, and
this was seen with beads from cells with no tagged protein (data not
shown). This background activity is probably caused by contamination of
the IgG-Sepharose beads by endogenous mannosyltransferases. Examination
of IgG-Sepharose precipitations from appropriate strains indicated that
this activity was entirely dependent on Och1p and Mnn1p, and is perhaps
due to the presence of glycans on the IgG as at least Och1p has an
affinity for large N-glycan structures (16).
|
|
 |
DISCUSSION |
The synthesis of the mannan structure attached to a subset of
yeast glycoproteins starts with the generation of an
-1,6-linked backbone. Mutations in the related Golgi membrane proteins Mnn9p and
Van1p result in the production of glycoproteins lacking this backbone
structure, and the two proteins have been found to be physically
associated. In this paper we report that the Mnn9p-Van1p complex that
we term M-Pol I comprises a single copy of each of the proteins. Our
previous analysis of the complex by gel filtration in the presence of
detergent had indicated an apparent molecular size of ~280 kDa (23).
This is clearly larger that the sum of the predicted molecular sizes of
Mnn9p and Van1p (107 kDa). However, the complex analyzed by gel
filtration will have also included a detergent micelle and the
N-linked glycans known to be present on Van1p (22), and so
we assume that these, in combination with the shape of the complex,
cause the complex to migrate more slowly that its stoichiometry would predict.
We also find from mutation of the putative active sites of Mnn9p and
Van1p that both proteins appear to contribute directly to the enzymatic
synthesis of the mannan backbone. Glycosylated lysozyme-G49N produced
by cells in which the DXD motif in Mnn9p was mutated had a
higher mobility than that produced in cells with the corresponding
mutation in Van1p. This suggests that Mnn9p is responsible for
attaching the first
-1,6-mannose in the backbone, and that the Van1p
in the complex, although active in vitro on simple
substrates, cannot modify a glycoprotein substrate in vivo until Mnn9p has attached this first mannose (Fig.
6). This model is accordance with the
N-glycan structures previously observed in strains lacking
Mnn9p or Van1p. Deletion of Mnn9p destabilizes Van1p (53), and in the
effective absence of both proteins no
-1,6-linked mannose is
attached to the Och1p product (52). However, in strains lacking Van1p
it was found that the N-linked glycans had a single
-1,6-linked mannose attached to the Och1p product to generate a
mannan backbone of two residues, a proportion of which were also
terminated with an
-1,2-linked residue (13) (vrg1 being
allelic to van1, Ref. 4). This implies that in the absence
of Van1p there is sufficient residual Mnn9p to add the first residue of
the backbone, but that this is not extended further. After Mnn9p has
attached the first mannose, the addition of the subsequent 10-15
mannoses to the backbone by M-Pol I could be mediated by Van1p alone,
as we find that the complex can still generate
-1,6-linked polymers
in vitro when Mnn9p is inactivated by the AXD
mutation, or alternatively by both proteins acting in concert.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 6.
A speculative model for the action of M-Pol I
on glycoprotein substrates in the yeast Golgi. When yeast
glycoproteins arrive in the Golgi from the ER they are initially
modified by the addition of an -1,6-mannose by Och1p (for clarity
only four of the mannoses in the GlcNAc2Man8
ER-derived structure are shown). The addition of mannan requires the
initiation of the -1,6-mannan backbone by M-Pol I. Our results
suggest that Mnn9p adds the first of the -1,6-linked mannoses
(gray) and that subsequent extension requires Van1p. It is
not clear if Mnn9p is also required for this subsequent extension
reaction, but either one or both active sites must then extend the
-1,6-linked polymer for about 10-15 residues before the substrate
is released for further extension by M-Pol II. Substrates that do not
have mannan attached receive instead an -1,2-linked mannose and this
could be added, at least in part, by the -1,2-transferase activity
of Mnn9p (italics). The resulting product would not
be further modified by Van1p or Mnn9p, and would be released for
addition of terminal -1,3-linked mannoses by Mnn1p, to complete the
core-type structure. In such a model, features of the protein could
determine which linkage is added by Mnn9p, and hence the type of glycan
that the protein acquires. Simple substrates such as -1,6-mannobiose
might be able to obtain direct access to the Van1p active site, even
though larger glycoprotein substrates could not until the mannan
backbone is extended by at least one residue by Mnn9p.
|
|
The mannan backbone contains only
-1,6-linked mannoses, and so its
synthesis will require only this transferase activity. However, we have
previously found that M-Pol I can also attach an
-1,2-linked mannose
to
-1,6-mannobiose in vitro (22, 23). The results above
indicate that this activity it mediated by Mnn9p. Glycoproteins that do
receive mannan are found to have instead an
-1,2-linked mannose
attached to the
-1,6-mannose added by Och1p (Fig. 1), and this has
been proposed to act as a stop signal to prevent further extension (18,
54). The N-glycan that receives either mannan or this
-1,2-linked residue has the same structure, indicating that the
modification fate of glycoproteins must reflect the recognition of
features of the proteins themselves. The fact that Mnn9p apparently
attaches the first
-1,6-linked mannose in the mannan synthesis
pathway, leads us to speculate that this subunit of M-Pol I interacts
directly with both glycan and protein. Then, depending on the nature of
the interaction with the protein moiety, Mnn9p would add either an
-1,6- or
-1,2-linked mannose (Fig. 6). If an
-1,6-linked
mannose is attached, then the mannan backbone would be further extended
by M-Pol I in a Van1p-dependent manner. However, if an
-1,2-linked mannose is attached then the substrate would be released
and be resistant to further modification by M-Pol I. Of course this is
simply one possible model that is consistent with our data. It may be
that M-Pol I primarily interacts with only those glycoproteins that
receive mannan, and that another enzyme is responsible for attaching
the
-1,2-linked residue to the rest. Indeed, it is known that in the
absence of Mnn9p,
-1,2-linked mannose is added to even those
proteins that would receive mannan (52), perhaps by members of the
large MNT1/KRE2 family of
-1,2-mannosyltransferases involved in extension of
O-linked glycans (20). Alternatively, more elaborate
scenarios are possible such as the involvement of adaptor proteins that
present the mannan-requiring glycoproteins to M-Pol I. In any case, it
is not at present clear what features of the proteins that receive
mannan distinguish them from those that do not. Ultimately, resolution
of these issues will require in vitro assays with a number
of different glycoprotein substrates, and structural analysis. The
observation that lysozyme-G49N can serve as a substrate for
modification by purified M-Pol I indicates that this sort of in
vitro approach should be feasible.
Proteins closely related to Mnn9p and Van1p are encoded in the genomes
of many other yeasts and fungi, including Candida, Histoplasma, S. pombe, and
Aspergillus. These organisms contain mannan-like cell wall
glycans, although the side branches are highly variable between
species, and for Candida it has been shown that an Mnn9p
homologue is involved in mannan synthesis (55-58). Although
Mnn9p-containing protein complexes in these species have not so far
been reported, it seems likely that the mechanisms that determine which
proteins receive mannan in S. cerevisiae will be conserved
in other yeasts and fungi.
Although there are no close relatives of the Mnn9p family in the
genomes of higher eukaryotes, a number of mammalian Golgi glycosyltransferases have also been found to be in specific multienzyme complexes. These include exostosin-1 and
2 that are required to
generate the polymer of alternating glucuronic acid and
N-acetylglucosamine residues that forms the basis of heparan
sulfate. Both proteins have conserved DXD motifs, and form a
hetero-oligomer of unknown stoichiometry (59-61). As with Mnn9p and
Van1p, mutation in either protein is sufficient to generate a
phenotype. It may be that arrangement of transferases into a complex
helps to generate polymeric structures more rapidly, and indeed some
enzymes that make polymers contain two glycosyltransferase domains in a
single polypeptide chain (62). However, it has recently been reported
that a complex is formed between two Golgi glycosyltransferases that
are not involved in polymer synthesis, but rather catalyze successive steps in a pathway of glycolipid synthesis (63). In this case the
physical association of the enzymes may ensure that substrates are
handled efficiently, or are channeled down a particular modification pathway. For M-Pol I it is not at present clear whether the association of Mnn9p and Van1p reflects two enzymes acting alternately in several
cycles to generate a polymer, or acting sequentially with Mnn9p first
selecting substrates, and then Van1p extending the subset that will
receive mannan. In the case of M-Pol II, five putative transferases
form a complex that simply extends the mannan backbone on all
substrates modified by M-Pol I, and here it seems likely that complex
formation is to facilitate the rapid generation of a 50-100-residue
polymer. What seems certain though is that the arrangement of Golgi
glycosyltransferases into complexes will prove to be an important
aspect of the specificity and nature of glycan synthesis.
 |
ACKNOWLEDGEMENTS |
We would like to thank the referees for
helpful comments.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by EMBO Long Term Fellowship ALTF 495-1999. Present
address: Lehrstuhl für Zellbiologie und Pflanzenphysiologie, Universität Regensburg, Universitätsstr. 31, D-93040
Regensburg, Germany.
§
To whom correspondence should be addressed. Tel.: 44-1223- 402336;
Fax: 44-1223-412142; E-mail: sean@mrc-lmb.cam.ac.uk.
Published, JBC Papers in Press, September 15, 2002, DOI 10.1074/jbc.M208023200
 |
ABBREVIATIONS |
The abbreviations used are:
ER, endoplasmic reticulum;
HA, hemagglutinin;
endo H, endoglycosidase H;
PIPES, 1,4-piperazinediethanesulfonic acid;
FACE, fluorophore-assisted
carbohydrate electrophoresis.
 |
REFERENCES |
| 1.
|
Helenius, A.,
and Aebi, M.
(2001)
Science
291,
2364-2369[Abstract/Free Full Text]
|
| 2.
|
Drickamer, K.,
and Taylor, M. E.
(1998)
Trends Biochem. Sci
23,
321-324[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Dennis, J. W.,
Granovsky, M.,
and Warren, C. E.
(1999)
Bioessays
21,
412-421[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Dean, N.
(1999)
Biochim. Biophys. Acta
1426,
309-322[Medline]
[Order article via Infotrieve]
|
| 5.
|
Munro, S.
(2001)
FEBS Lett.
498,
223-227[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Nakanishishindo, Y.,
Nakayama, K.,
Tanaka, A.,
Toda, Y.,
and Jigami, Y.
(1993)
J. Biol. Chem.
268,
26338-26345[Abstract/Free Full Text]
|
| 7.
|
Ballou, L.,
Cohen, R. E.,
and Ballou, C. E.
(1980)
J. Biol. Chem.
255,
5986-5991[Free Full Text]
|
| 8.
|
Osmond, B. C.,
Specht, C. A.,
and Robbins, P. W.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
11206-11210[Abstract/Free Full Text]
|
| 9.
|
Neiman, A. M.,
Mhaiskar, V.,
Manus, V.,
Galibert, F.,
and Dean, N.
(1997)
Genetics
145,
637-645[Abstract]
|
| 10.
|
de Nobel, H.,
van Den Ende, H.,
and Klis, F. M.
(2000)
Trends Microbiol.
8,
344-345[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Cullen, P. J.,
Schultz, J.,
Horecka, J.,
Stevenson, B. J.,
Jigami, Y.,
and Sprague, G. F., Jr.
(2000)
Genetics
155,
1005-1018[Abstract/Free Full Text]
|
| 12.
|
Horie, T.,
and Isono, K.
(2001)
Yeast
18,
1493-1503[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Ballou, L.,
Hitzeman, R. A.,
Lewis, M. S.,
and Ballou, C. E.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
3209-3212[Abstract/Free Full Text]
|
| 14.
|
Dean, N.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
1287-1291[Abstract/Free Full Text]
|
| 15.
|
Ram, A. F. J.,
Wolters, A.,
Tenhoopen, R.,
and Klis, F. M.
(1994)
Yeast
10,
1019-1030[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Nakayama, K.,
Nagasu, T.,
Shimma, Y.,
Kuromitsu, J.,
and Jigami, Y.
(1992)
EMBO J.
11,
2511-2519[Medline]
[Order article via Infotrieve]
|
| 17.
|
Lewis, M. S.,
and Ballou, C. E.
(1991)
J. Biol. Chem.
266,
8255-8261[Abstract/Free Full Text]
|
| 18.
|
Trimble, R. B.,
and Atkinson, P. H.
(1986)
J. Biol. Chem.
261,
9815-9824[Abstract/Free Full Text]
|
| 19.
|
Rayner, J. C.,
and Munro, S.
(1998)
J. Biol. Chem.
273,
26836-26843[Abstract/Free Full Text]
|
| 20.
|
Lussier, M.,
Sdicu, A. M.,
and Bussey, H.
(1999)
Biochim. Biophys. Acta
1426,
323-334[Medline]
[Order article via Infotrieve]
|
| 21.
|
Kojima, H.,
Hashimoto, H.,
and Yoda, K.
(1999)
Biosci Biotechnol. Biochem.
63,
1970-1976[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Jungmann, J.,
and Munro, S.
(1998)
EMBO J.
17,
423-434[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Jungmann, J.,
Rayner, J. C.,
and Munro, S.
(1999)
J. Biol. Chem.
274,
6579-6585[Abstract/Free Full Text]
|
| 24.
|
Hernandez, L. M.,
Ballou, L.,
Alvarado, E.,
Gillece-Castro, B. L.,
Burlingame, A. L.,
and Ballou, C. E.
(1989)
J. Biol. Chem.
264,
11849-11856[Abstract/Free Full Text]
|
| 25.
|
Yip, C. L.,
Welch, S. K.,
Klebl, F.,
Gilbert, T.,
Seidel, P.,
Grant, F. J.,
O'Hara, P. J.,
and MacKay, V. L.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
2723-2727[Abstract/Free Full Text]
|
| 26.
|
Chapman, R. E.,
and Munro, S.
(1994)
EMBO J.
13,
4896-4907[Medline]
[Order article via Infotrieve]
|
| 27.
|
Kanik-Ennulat, C.,
and Neff, N.
(1990)
Mol. Cell. Biol.
10,
898-909[Abstract/Free Full Text]
|
| 28.
|
Unligil, U. M.,
and Rini, J. M.
(2000)
Curr. Opin. Struct. Biol.
10,
510-517[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Wiggins, C. A. R.,
and Munro, S.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
7945-7950[Abstract/Free Full Text]
|
| 30.
|
Saxena, I. M.,
and Brown, R. M.
(2000)
Curr. Opin. Plant Biol.
3,
523-531[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Unligil, U. M.,
Zhou, S.,
Yuwaraj, S.,
Sarkar, M.,
Schachter, H.,
and Rini, J. M.
(2000)
EMBO J.
19,
5269-5280[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Gastinel, L. N.,
Cambillau, C.,
and Bourne, Y.
(1999)
EMBO J.
18,
3546-3557[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Gastinel, L. N.,
Bignon, C.,
Misra, A. K.,
Hindsgaul, O.,
Shaper, J. H.,
and Joziasse, D. H.
(2001)
EMBO J.
20,
638-649[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Gibbons, B. J.,
Roach, P. J.,
and Hurley, T. D.
(2002)
J. Mol. Biol.
319,
463-477[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Munro, S.,
and Freeman, M.
(2000)
Curr. Biol.
10,
813-820[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Hagen, F. K.,
Hazes, B.,
Raffo, R.,
deSa, D.,
and Tabak, L. A.
(1999)
J. Biol. Chem.
274,
6797-6803[Abstract/Free Full Text]
|
| 37.
|
Li, J. G.,
Rancour, D. M.,
Allende, M. L.,
Worth, C. A.,
Darling, D. S.,
Gilbert, J. B.,
Menon, A. K.,
and Young, W. W.
(2001)
Glycobiology
11,
217-229[Abstract/Free Full Text]
|
| 38.
|
Marks, D. L.,
Dominguez, M., Wu, K.,
and Pagano, R. E.
(2001)
J. Biol. Chem.
276,
26492-26498[Abstract/Free Full Text]
|
| 39.
|
Robinson, J. S.,
Klionsky, D. J.,
Banta, L. M.,
and Emr, S. D.
(1988)
Mol. Cell. Biol.
8,
4936-4948[Abstract/Free Full Text]
|
| 40.
|
Wach, A.,
Brachat, A.,
AlbertiSegui, C.,
Rebischung, C.,
and Philippsen, P.
(1997)
Yeast
13,
1065-1075[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Tessier, D. C.,
Dignard, D.,
Zapun, A.,
Radominska-Pandya, A.,
Parodi, A. J.,
Bergeron, J. J.,
and Thomas, D. Y.
(2000)
Glycobiology
10,
403-412[Abstract/Free Full Text]
|
| 42.
|
Heinemeyer, W.,
Kleinschmidt, J. A.,
Saidowsky, J.,
Escher, C.,
and Wolf, D. H.
(1991)
EMBO J.
10,
555-562[Medline]
[Order article via Infotrieve]
|
| 43.
|
Vernet, T.,
Dignard, D.,
and Thomas, D. Y.
(1987)
Gene (Amst.)
52,
225-233[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Nacken, V.,
Achstetter, T.,
and Degryse, E.
(1996)
Gene (Amst.)
175,
253-260[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Gietz, R. D.,
and Sugino, A.
(1988)
Gene (Amst.)
74,
527-534[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Jackson, P.
(1994)
Methods Enzymol.
230,
250-265[Medline]
[Order article via Infotrieve]
|
| 47.
|
Scherer, S.,
and Davis, R. W.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4951-4955[Abstract/Free Full Text]
|
| 48.
|
Nakamura, S.,
Takasaki, H.,
Kobayashi, K.,
and Kato, A.
(1993)
J. Biol. Chem.
268,
12706-12712[Abstract/Free Full Text]
|
| 49.
|
Horst, M.,
Harth, N.,
and Hasilik, A.
(1991)
J. Biol. Chem.
266,
13914-13919[Abstract/Free Full Text]
|
| 50.
|
Hummel, M.,
Hedrich, H. C.,
and Hasilik, A.
(1997)
Eur. J. Biochem.
245,
428-433[Medline]
[Order article via Infotrieve]
|
| 51.
|
Alvarado, E.,
Ballou, L.,
Hernandez, L. M.,
and Ballou, C. E.
(1990)
Biochemistry
29,
2471-2482[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Hernandez, L. M.,
Ballou, L.,
Alvarado, E.,
Tsai, P. K.,
and Ballou, C. E.
(1989)
J. Biol. Chem.
264,
13648-13659[Abstract/Free Full Text]
|
| 53.
|
Hashimoto, H.,
and Yoda, K.
(1997)
Biochem. Biophys. Res. Commun.
241,
682-686[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Gopal, P. K.,
and Ballou, C. E.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
8824-8828[Abstract/Free Full Text]
|
| 55.
|
Southard, S. B.,
Specht, C. A.,
Mishra, C.,
Chen-Weiner, J.,
and Robbins, P. W.
(1999)
J. Bacteriol.
181,
7439-7448[Abstract/Free Full Text]
|
| 56.
|
Ikuta, K.,
Shibata, N.,
Blake, J. S.,
Dahl, M. V.,
Nelson, R. D.,
Hisamichi, K.,
Kobayashi, H.,
Suzuki, S.,
and Okawa, Y.
(1997)
Biochem. J.
323,
297-305[Medline]
[Order article via Infotrieve]
|
| 57.
|
Ballou, L.,
and Ballou, C.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
2790-2794[Abstract/Free Full Text]
|
| 58.
|
Shibata, N.,
Ikuta, K.,
Imai, T.,
Satoh, Y.,
Satoh, R.,
Suzuki, A.,
Kojima, C.,
Kobayashi, H.,
Hisamichi, K.,
and Suzuki, S.
(1995)
J. Biol. Chem.
270,
1113-1122[Abstract/Free Full Text]
|
| 59.
|
Wei, G.,
Bai, X.,
Gabb, M. M.,
Bame, K. J.,
Koshy, T. I.,
Spear, P. G.,
and Esko, J. D.
(2000)
J. Biol. Chem.
275,
27733-27740[Abstract/Free Full Text]
|
| 60.
|
McCormick, C.,
Duncan, G.,
Goutsos, K. T.,
and Tufaro, F.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
668-673[Abstract/Free Full Text]
|
| 61.
|
Kobayashi, S.,
Morimoto, K.,
Shimizu, T.,
Takahashi, M.,
Kurosawa, H.,
and Shirasawa, T.
(2000)
Biochem. Biophys. Res. Commun.
268,
860-867[CrossRef][Medline]
[Order article& |